Obermatt
See Similar Stocks →

Health In Tech

NAQ:HIT · US42217D1028
InsuranceSmall

360

85
Profit price—
Cash yield1
Price/Sales80
EV / Gross Profit53
Price/Book34
Returns on capital—
Profit margins10

Cash truth not applicable for financial companies.

Sales growth76
Profit Growth34
Long-Term EPS Growth4
Reinvestment16
Price momentum75
Debt load97
Debt serviceability77
Liquidity55
Analyst ratings72
Opinion Changes50
Price Target Upside100
Market mood81
Value Creation7/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Health In Tech clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryUSA
IndustryInsurance
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2021
Employees64
Websitehealthintech.com
ISINUS42217D1028
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
HRTechInsurtechEmployee BenefitsHealth InsuranceInformation TechnologyInsurance

Description

Health In Tech, Inc. (HIT) AI-enabled insurance technology platform company. The company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing fricti…

Analysis

Hope premium

Health In Tech, Inc. is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium.

Valuation data is not available for this company.

Growth is solid; the safety picture is sturdy. The company scores 7/20 on our value-creation score: creating some value. Analysts lean positive.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
80
—
—
—
Price/Earnings
1
—
—
—
Price/Book
34
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
19
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Health In Tech with its peers
Roadzen
NMQ:RDZN
29
CountryUSA
IndustrySoftware
SizeSmall
Full Stock Analysis →
Penguin Solutions
NSQ:PENG
95
CountryUSA
IndustrySemiconductors & Semiconductor Equipment
SizeMedium
Full Stock Analysis →
Enanta Pharmaceuticals
NSQ:ENTA
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Quicklogic
NAQ:QUIK
61
CountryUSA
IndustrySemiconductors & Semiconductor Equipment
SizeSmall
Full Stock Analysis →
Natera
NSQ:NTRA
39
CountryUSA
IndustryBiotechnology
SizeLarge
Full Stock Analysis →
Kyndryl Holdings
NYQ:KD
33
CountryUSA
IndustryIT Services
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →